Table 5. The distributional comparison between clinical prognostic and pathologic prognostic stage among patients treated without neoadjuvant chemotherapy.
| Anatomic stage | Clinical prognostic stage | Pathologic prognostic stage | No. (%) | |
|---|---|---|---|---|
| IA (n = 10,679) | Consistent cases | IA | IA | 8,856 (82.9) |
| IB | IB | 1,492 (14.0) | ||
| Inconsistent cases | IB | IA | 331 (3.1) | |
| IB (n = 385) | Consistent cases | IA | IA | 324 (84.2) |
| IB | IB | 45 (11.6) | ||
| Inconsistent cases | IB | IA | 16 (4.2) | |
| IIA (n = 6,525) | Consistent cases | IA | IA | 1 (0) |
| IIA | IIA | 1,130 (17.3) | ||
| Inconsistent cases | IB | IA | 2,977 (45.6) | |
| IIA | IA | 1 (0) | ||
| IIA | IB | 816 (12.5) | ||
| IIB | IIA | 1,535 (23.5) | ||
| IIIA | IIA | 64 (1.0) | ||
| IIIB | IIA | 1 (0) | ||
| IIB (n = 3,232) | Consistent cases | IA | IA | 1 (0) |
| IB | IB | 224 (6.9) | ||
| IIB | IIB | 652 (20.2) | ||
| Inconsistent cases | IB | IA | 13 (0.4) | |
| IB | IIB | 1 (0) | ||
| IIA | IA | 260 (8.0) | ||
| IIA | IB | 879 (27.2) | ||
| IIA | IIB | 67 (2.1) | ||
| IIB | IIA | 398 (12.3) | ||
| IIB | IIIA | 1 (0) | ||
| IIIA | IIB | 166 (5.1) | ||
| IIIB | IIB | 95 (2.9) | ||
| IIIB | IIIA | 475 (14.7) | ||
| IIIA (n = 810) | Consistent cases | IIIA | IIIA | 182 (22.5) |
| IIIB | IIIB | 21 (2.6) | ||
| IIIC | IIIC | 105 (13.0) | ||
| Inconsistent cases | IIA | IB | 320 (39.5) | |
| IIB | IIA | 33 (4.1) | ||
| IIIA | IIB | 118 (14.6) | ||
| IIIB | IIIA | 31 (3.8) | ||
| IIIB (n = 40) | Consistent cases | IIIA | IIIA | 3 (7.5) |
| IIIB | IIIB | 14 (35.0) | ||
| IIIC | IIIC | 6 (15.0) | ||
| Inconsistent cases | IIIB | IIIA | 17 (42.5) | |
| IIIC (n = 887) | Consistent cases | IIIA | IIIA | 43 (4.8) |
| IIIB | IIIB | 407 (45.9) | ||
| IIIC | IIIC | 207 (23.3) | ||
| Inconsistent cases | IIIB | IIIA | 226 (25.5) | |
| IIIC | IIIB | 4 (0.5) | ||